Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Mallinckrodt
Chubb
Chinese Patent Office
AstraZeneca
Baxter
Boehringer Ingelheim
US Department of Justice

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205217

« Back to Dashboard

NDA 205217 describes LAMIVUDINE, which is a drug marketed by Aurobindo Pharma Ltd, Lannett Co Inc, Apotex, Apotex Inc, Appco Pharma Llc, Cipla Ltd, Eci Pharms Llc, Hetero Labs Ltd V, Lupin Ltd, Mylan Pharms Inc, Strides Pharma, Hetero Labs Ltd Iii, Pharmacare, Shanghai Desano, and Teva Pharms, and is included in twenty-five NDAs. It is available from twenty-one suppliers. Additional details are available on the LAMIVUDINE profile page.

The generic ingredient in LAMIVUDINE is lamivudine; zidovudine. There are twenty-eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the lamivudine; zidovudine profile page.
Summary for 205217
Tradename:LAMIVUDINE
Applicant:Lupin Ltd
Ingredient:lamivudine
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 205217
Medical Subject Heading (MeSH) Categories for 205217
Suppliers and Packaging for NDA: 205217
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LAMIVUDINE lamivudine TABLET;ORAL 205217 ANDA Lupin Pharmaceuticals, Inc. 68180-602 N 68180-602-01
LAMIVUDINE lamivudine TABLET;ORAL 205217 ANDA Lupin Pharmaceuticals, Inc. 68180-602 N 68180-602-07

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength150MG
Approval Date:Dec 18, 2014TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength300MG
Approval Date:Dec 18, 2014TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Teva
Chubb
Healthtrust
Mallinckrodt
Daiichi Sankyo
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.